Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (21)
Priscila O Barros, Tamara K Berthoud, Nawaf Aloufi & Jonathan B Angel. (2021) Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role as a Therapeutic Agent. ImmunoTargets and Therapy 10, pages 47-62.
Read now
Read now
Jonathan P. E. White & Laura C. Coates. (2021) The road to personalised medicine in psoriatic arthritis. Expert Review of Clinical Immunology 17:8, pages 799-802.
Read now
Read now
Giuseppe Murdaca, Simone Negrini, Marco Pellecchio, Monica Greco, Chiara Schiavi, Francesca Giusti & Francesco Puppo. (2019) Update upon the infection risk in patients receiving TNF alpha inhibitors. Expert Opinion on Drug Safety 18:3, pages 219-229.
Read now
Read now
Giuseppe Murdaca, Simone Negrini, Ottavia Magnani, Elena Penza, Marco Pellecchio, Rossella Gulli, Paola Mandich & Francesco Puppo. (2018) Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis. Modern Rheumatology 28:3, pages 417-431.
Read now
Read now
Giuseppe Murdaca, Simone Negrini, Ottavia Magnani, Elena Penza, Marco Pellecchio & Francesco Puppo. (2017) Impact of pharmacogenomics upon the therapeutic response to etanercept in psoriasis and psoriatic arthritis. Expert Opinion on Drug Safety 16:10, pages 1173-1179.
Read now
Read now
Natalie Boytsov, Leslie R. Harrold, Marc A. Mason, Carol L. Gaich, Xiang Zhang, Cynthia J. Larmore, Sabrina Rebello & Andre B. Araujo. (2016) Increased healthcare resource utilization in higher disease activity levels in initiators of TNF inhibitors among US rheumatoid arthritis patients. Current Medical Research and Opinion 32:12, pages 1959-1967.
Read now
Read now
Giuseppe Murdaca, Andrea Orsi, Francesca Spanò, Valeria Faccio, Francesco Puppo, Paolo Durando, Giancarlo Icardi & Filippo Ansaldi. (2016) Vaccine-preventable infections in Systemic Lupus Erythematosus. Human Vaccines & Immunotherapeutics 12:3, pages 632-643.
Read now
Read now
Livio Garattini, Francesca Ghislandi & Anna Padula. (2016) Older anti-TNF-α agents: why not group them for common indications in the EU?. Expert Review of Pharmacoeconomics & Outcomes Research 16:1, pages 1-4.
Read now
Read now
Giuseppe Murdaca, Francesca Spanò, Miriam Contatore, Andrea Guastalla, Elena Penza, Ottavia Magnani & Francesco Puppo. (2016) Immunogenicity of infliximab and adalimumab: what is its role in hypersensitivity and modulation of therapeutic efficacy and safety?. Expert Opinion on Drug Safety 15:1, pages 43-52.
Read now
Read now
Giuseppe Murdaca, Francesca Spanò, Miriam Contatore, Andrea Guastalla, Elena Penza, Ottavia Magnani & Francesco Puppo. (2015) Infection risk associated with anti-TNF-α agents: a review. Expert Opinion on Drug Safety 14:4, pages 571-582.
Read now
Read now
Giuseppe Murdaca, Francesca Spanò, Miriam Contatore, Andrea Guastalla, Ottavia Magnani & Francesco Puppo. (2014) Pharmacogenetics of etanercept: role of TNF-α gene polymorphisms in improving its efficacy. Expert Opinion on Drug Metabolism & Toxicology 10:12, pages 1703-1710.
Read now
Read now
Luciane Cruz Lopes, Miriam Sanches do Nascimento Silveira, Mayara Costa de Camargo, Iara Alves de Camargo, Tatiana Chama Borges Luz, Claudia Garcia Serpa Osorio-de-Castro, Silvio Barberato-Filho, Fernando de Sá Del Fiol & Gordon Guyatt. (2014) Patient reports of the frequency and severity of adverse reactions associated with biological agents prescribed for psoriasis in Brazil. Expert Opinion on Drug Safety 13:9, pages 1155-1163.
Read now
Read now
Giuseppe Murdaca, Francesca Spanò, Miriam Contatore, Andrea Guastalla, Ottavia Magnani & Francesco Puppo. (2014) Efficacy and safety of etanercept in chronic immune-mediated disease. Expert Opinion on Drug Safety 13:5, pages 649-661.
Read now
Read now
Paraskevi V Voulgari & Alexandros A Drosos. (2014)
Adalimumab in the treatment of rheumatoid arthritis. Expert Opinion on Biological Therapy 14:4, pages 549-561.
Read now
Read now
Giuseppe Murdaca, Francesca Spanò & Francesco Puppo. (2014) Current therapies for the treatment of systemic sclerosis-related pulmonary arterial hypertension: efficacy and safety. Expert Opinion on Drug Safety 13:3, pages 295-305.
Read now
Read now
Giuseppe Murdaca, Francesca Spanò & Francesco Puppo. (2013) Long-term treatment of rheumatoid arthritis with adalimumab. Open Access Rheumatology: Research and Reviews 5, pages 43-49.
Read now
Read now
Giuseppe Murdaca, Francesca Spanò & Francesco Puppo. (2013) Use of leflunomide plus TNF-α inhibitors in rheumatoid arthritis. Expert Opinion on Drug Safety 12:6, pages 801-804.
Read now
Read now
Giuseppe Murdaca, Francesca Spanò, Paola Cagnati & Francesco Puppo. (2013) Free radicals and endothelial dysfunction: Potential positive effects of TNF-α inhibitors. Redox Report 18:3, pages 95-99.
Read now
Read now
V.V. Barygina, M. Becatti, G. Soldi, F. Prignano, T. Lotti, P. Nassi, D. Wright, N. Taddei & C. Fiorillo. (2013) Altered redox status in the blood of psoriatic patients: involvement of NADPH oxidase and role of anti-TNF-α therapy. Redox Report 18:3, pages 100-106.
Read now
Read now
Giuseppe Murdaca, Francesca Spanò & Francesco Puppo. (2013) Selective TNF-α inhibitor-induced injection site reactions. Expert Opinion on Drug Safety 12:2, pages 187-193.
Read now
Read now
Aleksandra Batycka-Baran, Michael Flaig, Sonja Molin, Thomas Ruzicka & Joerg C Prinz. (2012) Etanercept-induced injection site reactions: potential pathomechanisms and clinical assessment. Expert Opinion on Drug Safety 11:6, pages 911-921.
Read now
Read now
Articles from other publishers (37)
Claudia Herrera León, Noel Angelo Kalacas, Alejandra Mier, Peyman Sakhaii, Franck Merlier, Elise Prost, Irene Maffucci, Valentina Montagna, Helena Mora‐Radó, Pradeep K. Dhal, Bernadette Tse Sum Bui & Karsten Haupt. (2023) Synthetic Peptide Antibodies as TNF‐α Inhibitors: Molecularly Imprinted Polymer Nanogels Neutralize the Inflammatory Activity of TNF‐α in THP‐1 Derived Macrophages. Angewandte Chemie 135:34.
Crossref
Crossref
Oh Chan Kwon, See Young Lee, Jaeyoung Chun, Kyungdo Han, Yuna Kim, Ryul Kim, Min-Chan Park, Jie-Hyun Kim, Young Hoon Youn & Hyojin Park. (2023) Risk of all-cause and cause-specific mortality associated with immune-mediated inflammatory diseases in Korea. Frontiers in Medicine 10.
Crossref
Crossref
Claudia Herrera León, Noel Angelo Kalacas, Alejandra Mier, Peyman Sakhaii, Franck Merlier, Elise Prost, Irene Maffucci, Valentina Montagna, Helena Mora-Radó, Pradeep K. Dhal, Bernadette Tse Sum Bui & Karsten Haupt. (2023) Synthetic Peptide Antibodies as TNF‐α Inhibitors: Molecularly Imprinted Polymer Nanogels Neutralize the Inflammatory Activity of TNF‐α in THP‐1 Derived Macrophages. Angewandte Chemie International Edition.
Crossref
Crossref
Fabio Venturella, Giulia Cancellieri, Marco Giammanco, Anna Maria Almerico, Igor Daniele Aleo, Anastasia Valentina Liga, Francesca Mortillaro & Irene Mistretta. (2023) Immuno-oncological treatment of Non-Small-Cell Lung Cancer (NSCLC) in advanced stage with Nivolumab. Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale 96:1.
Crossref
Crossref
Igor José dos Santos Nascimento & Edeildo Ferreira da Silva-Júnior. (2022) TNF-α Inhibitors from Natural Compounds: An Overview, CADD Approaches, and their Exploration for Anti-inflammatory Agents. Combinatorial Chemistry & High Throughput Screening 25:14, pages 2317-2340.
Crossref
Crossref
Juan Zhao, Xia Ye & Zhuoli Zhang. (2022) Syndecan-4 is correlated with disease activity and serological characteristic of rheumatoid arthritis. Advances in Rheumatology 62:1.
Crossref
Crossref
Liudan Tu, Minjing Zhao, Xiaohong Wang, Qingcong Kong, Zena Chen, Qiujing Wei, Qiuxia Li, Qinghong Yu, Zhizhong Ye, Shuangyan Cao, Zhimin Lin, Zetao Liao, Qing Lv, Jun Qi, Ou Jin, Yunfeng Pan & Jieruo Gu. (2022) Etanercept/celecoxib on improving MRI inflammation of active ankylosing spondylitis: A multicenter, open-label, randomized clinical trial. Frontiers in Immunology 13.
Crossref
Crossref
Yu Tai, Bei Huang, Pai-pai Guo, Zhen Wang, Zheng-wei Zhou, Man-man Wang, Han-fei Sun, Yong Hu, Sheng-lin Xu, Ling-ling Zhang, Qing-tong Wang & Wei Wei. (2021) TNF-α impairs EP4 signaling through the association of TRAF2-GRK2 in primary fibroblast-like synoviocytes. Acta Pharmacologica Sinica 43:2, pages 401-416.
Crossref
Crossref
Florin Bujoreanu, Laura Bezman, Diana Radaschin, Elena Niculet, Carmen Bobeica, Mihaela Craescu, Thomas Nadasdy, Daniela Jicman, Valeriu Ardeleanu, Lawrence Nwabudike, Silviu Marinescu & Alin Tatu. (2021) Nevi, biologics for psoriasis and the risk for skin cancer: A real concern? (Case presentation and short review). Experimental and Therapeutic Medicine 22:6.
Crossref
Crossref
Mehret Birru Talabi, Amanda M. Eudy, Malithi Jayasundara, Tayseer Haroun, W. Benjamin Nowell, Jeffrey R. Curtis, Rachelle Crow‐Hercher, Whitney White, Seth Ginsberg & Megan E. B. Clowse. (2021) Tough Choices: Exploring Medication Decision‐Making During Pregnancy and Lactation Among Women With Inflammatory Arthritis. ACR Open Rheumatology 3:7, pages 475-483.
Crossref
Crossref
Abhinandan Devaprasad, Timothy R. D. J. Radstake & Aridaman Pandit. (2021) Integration of Immunome With Disease-Gene Network Reveals Common Cellular Mechanisms Between IMIDs and Drug Repurposing Strategies. Frontiers in Immunology 12.
Crossref
Crossref
Guoying Cao, Jicheng Yu, Jufang Wu, Jingjing Wang, Yu Xue, Xiaoli Yang & Jing Zhang. (2020) A Randomized, Double‐Blind, Parallel‐Group, Phase 1 Clinical Trial Comparing the Pharmacokinetic, Safety, and Immunogenicity of the Biosimilar HS016 and the Originator Adalimumab in Chinese Healthy Male Subjects. Clinical Pharmacology in Drug Development 10:3, pages 317-325.
Crossref
Crossref
Mohammad-Esmaeil Hejazi, Atefeh Ahmadzadeh, Alireza Khabbazi, Aliasghar Ebrahimi, Maryam Farmani & Yasin Hejazi. (2020) Tuberculin skin test conversion in patients under treatment with anti-tumor necrotizing factor alpha agents. BMC Infectious Diseases 20:1.
Crossref
Crossref
Shamarke Esse, Kayleigh J. Mason, Adele C. Green & Richard B. Warren. (2020) Melanoma Risk in Patients Treated With Biologic Therapy for Common Inflammatory Diseases. JAMA Dermatology 156:7, pages 787.
Crossref
Crossref
Nan Zhang, Ziyi Wang & Yongxing Zhao. (2020) Selective inhibition of Tumor necrosis factor receptor-1 (TNFR1) for the treatment of autoimmune diseases. Cytokine & Growth Factor Reviews.
Crossref
Crossref
Mayara Costa de Camargo, Bruna Cipriano Almeida Barros, Izabela Fulone, Marcus Tolentino Silva, Miriam Sanches do Nascimento Silveira, Iara Alves de Camargo, Silvio Barberato-Filho, Fernando de Sá Del Fiol & Luciane Cruz Lopes. (2019) Adverse Events in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Receiving Long-Term Biological Agents in a Real-Life Setting. Frontiers in Pharmacology 10.
Crossref
Crossref
Kurt R Oelke, Olivier Chambenoit, Amar Q Majjhoo, Stephani Gray, Kate Higgins & Peter Hur. (2019) Persistence and adherence of biologics in US patients with psoriatic arthritis: analyses from a claims database. Journal of Comparative Effectiveness Research 8:8, pages 607-621.
Crossref
Crossref
Zunera Tahir & Arthur Kavanaugh. (2018) The role of golimumab in inflammatory arthritis. A review of the evidence. Therapeutic Advances in Musculoskeletal Disease 10:9, pages 181-194.
Crossref
Crossref
Heejin Lim, Sang Lee, Hyun Lee, Jee Lee, Ji Son, Woori Shin & Yong-Seok Heo. (2018) Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid Arthritis. International Journal of Molecular Sciences 19:3, pages 768.
Crossref
Crossref
Catherine Shepherd, Paul Giacomin, Severine Navarro, Catherine Miller, Alex Loukas & Phurpa Wangchuk. (2018) A medicinal plant compound, capnoidine, prevents the onset of inflammation in a mouse model of colitis. Journal of Ethnopharmacology 211, pages 17-28.
Crossref
Crossref
Jee Lee, Woori Shin, Ji Son, Ki-Young Yoo & Yong-Seok Heo. (2017) Molecular Basis for the Neutralization of Tumor Necrosis Factor α by Certolizumab Pegol in the Treatment of Inflammatory Autoimmune Diseases. International Journal of Molecular Sciences 18:1, pages 228.
Crossref
Crossref
Karin A. van Schie, Pleuni Ooijevaar-de Heer, Lisanne Dijk, Simone Kruithof, Gertjan Wolbink & Theo Rispens. (2016) Therapeutic TNF Inhibitors can Differentially Stabilize Trimeric TNF by Inhibiting Monomer Exchange. Scientific Reports 6:1.
Crossref
Crossref
Heather Yvonne SmallRyszard NosalskiHannah MorganElisabeth BeattieTomasz J. GuzikDelyth GrahamChristian Delles. (2016) Role of Tumor Necrosis Factor-α and Natural Killer Cells in Uterine Artery Function and Pregnancy Outcome in the Stroke-Prone Spontaneously Hypertensive Rat. Hypertension 68:5, pages 1298-1307.
Crossref
Crossref
Xiao Hu, Fang Yuan, Jian Zhang, Lei Yin, Bi-Ru Li & Yan-Liang Jin. (2015) Effect of etanercept on refractory systemic-onset juvenile idiopathic arthritis. World Journal of Pediatrics 12:1, pages 96-102.
Crossref
Crossref
Giuseppe Murdaca, Rodolfo Russo, Francesca Spanò, Diego Ferone, Manuela Albertelli, Angelo Schenone, Miriam Contatore, Andrea Guastalla, Annamaria De Bellis, Giacomo Garibotto & Francesco Puppo. (2015) Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response. Archives of Endocrinology and Metabolism 59:6, pages 554-558.
Crossref
Crossref
Rui Pereira, Paula Lago, Raquel Faria & Tiago Torres. (2015) Safety of Anti-TNF Therapies in Immune-Mediated Inflammatory Diseases: Focus on Infections and Malignancy. Drug Development Research 76:8, pages 419-427.
Crossref
Crossref
Yesim Garip. (2015) Use of biologic agents for rheumatic diseases in pregnancy. World Journal of Rheumatology 5:2, pages 50.
Crossref
Crossref
Eric M. George. (2014) New Approaches for Managing Preeclampsia: Clues From Clinical and Basic Research. Clinical Therapeutics 36:12, pages 1873-1881.
Crossref
Crossref
Giuseppe Murdaca, Rossella Gulli, Francesca Spanò, Paola Mandich & Francesco Puppo. (2014) Pharmacogenetics and Future Therapeutic Scenarios: What Affects the Prediction of Response to Treatment with Etanercept?. Drug Development Research 75, pages S7-S10.
Crossref
Crossref
Giuseppe Murdaca, Rossella Gulli, Francesca Spanò, Francesca Lantieri, Martina Burlando, Aurora Parodi, Paola Mandich & Francesco Puppo. (2014) TNF-α Gene Polymorphisms: Association with Disease Susceptibility and Response to Anti-TNF-α Treatment in Psoriatic Arthritis. Journal of Investigative Dermatology 134:10, pages 2503-2509.
Crossref
Crossref
Alessandra Vultaggio & Mariana C. Castells. (2014) Hypersensitivity Reactions to Biologic Agents. Immunology and Allergy Clinics of North America 34:3, pages 615-632.
Crossref
Crossref
Kevin H. Toomer & Zhibin Chen. (2014) Autoimmunity as a Double Agent in Tumor Killing and Cancer Promotion. Frontiers in Immunology 5.
Crossref
Crossref
Giuseppe Murdaca, Francesca Spanò, Miriam Contatore, Andrea Guastalla & Francesco Puppo. (2014) Potential use of TNF-α inhibitors in systemic sclerosis. Immunotherapy 6:3, pages 283-289.
Crossref
Crossref
Giuseppe Murdaca, Andrea Orsi, Francesca Spanò, Francesco Puppo, Paolo Durando, Giancarlo Icardi & Filippo Ansaldi. (2014) Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: Current views upon safety and immunogenicity. Autoimmunity Reviews 13:2, pages 75-84.
Crossref
Crossref
Giuseppe MurdacaFrancesca Spanò, Maurizio Miglino & Francesco Puppo. (2013) Effects of TNF-α inhibitors upon the mechanisms of action of VEGF. Immunotherapy 5:2, pages 113-115.
Crossref
Crossref
Nelson S. Yee. 2013. Impact of Genetic Targets on Cancer Therapy. Impact of Genetic Targets on Cancer Therapy
91
143
.
Christina D. Chambers & Diana L. Johnson. (2012) Emerging data on the use of anti-tumor necrosis factor-alpha medications in pregnancy. Birth Defects Research Part A: Clinical and Molecular Teratology 94:8, pages 607-611.
Crossref
Crossref